MedTrace Logo

Effect of Different Probiotic Strains in Hypercholesterolemic Patients

NCT04701775 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-01-12

No results posted yet for this study

Summary

Regular probiotic use for 8 weeks was evaluated in individual with mild to moderate hyperlipidemia. Current study have been determined the use of different probiotics strains on lipid parameters such as; total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride levels as well as glycemic parameters such as; glucose, insulin, HOMA-IR levels. Also, hs-CRP levels were investigated as inflammatory parameter.

Conditions

  • Hyperlipidemias

Interventions

DIETARY_SUPPLEMENT

Only Lactobacillus rhamnosus GG strains

1x106 colony forming unit (CFU) Lactobacillus rhamnosus GG probiotic capsule

COMBINATION_PRODUCT

Combined Lactobacillus acidophilus and Bifidobacterium animalis subsp.lactis strains

combination of Lactobacillus acidophilus 1x109 CFU and Bifidobacterium animalis subsp.lactis 1x109 CFU probiotic capsule

OTHER

Placebo

Placebo probiotic capsule

Sponsors & Collaborators

  • Eastern Mediterranean University

    lead OTHER

Principal Investigators

  • Gözde Okburan · Eastern Medittanean University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-28
Primary Completion
2019-02-01
Completion
2019-03-07

Countries

  • Cyprus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04701775 on ClinicalTrials.gov